Program overview
Context
Indication: Non-small Cell Lung Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Guangdong Provincial People's Hospital
Watchlist Signal
Envafolimab injections+intravenous Disitamab Vedotin+carboplatin
Envafolimab injections+intravenous Disitamab Vedotin+carboplatin is flagged as watchlist signal because public records show timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 1/5
Timeline: 2/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 2/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT06734182
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT06734182 | Low Signal (RECRUITING) | stale_update_signal | long_recruitment_duration_signal | Low Signal | rare_population_signal | strict_eligibility_signal |